Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana
- 1 September 2007
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (9) , 3273-3281
- https://doi.org/10.1128/aac.00513-07
Abstract
Morbidity and mortality from malaria remain unacceptably high among young children in sub-Saharan Africa. Intermittent preventive treatment in infancy (IPTi) involves the administration of antimalarials alongside routine vaccinations and might be an option in malaria control. In an area of intense, perennial malaria transmission in northern Ghana, 1,200 children received IPTi with sulfadoxine-pyrimethamine or placebo at approximately 3, 9, and 15 months of age. Children were followed up until 24 months of age to assess morbidity and adverse events. During the intervention period (3 to 18 months of age), IPTi reduced the incidences of malaria and severe anemia by 22.5% (95% confidence interval, 12 to 32%) and 23.6% (95% confidence interval, 4 to 39%), respectively, and reduced hospitalizations and episodes of asymptomatic parasitemia by one-third. Protection was pronounced in the first year of life and not discernible in the second. The malaria-protective effect was largely confined to a period of 1 month after sulfadoxine-pyrimethamine treatments. Following the intervention, protection against asymptomatic parasitemia persisted. In contrast, a significant rebound of severe malaria, predominantly severe malarial anemia, occurred among children having received IPTi. Although the treatment was generally well tolerated, one case of moderately severe skin reaction followed sulfadoxine-pyrimethamine treatment. IPTi reduces malaria and anemia in infants in northern Ghana. Extension of IPTi into the second year of life by administering a dose at 15 months of age provided no substantial benefit beyond a 1-month prophylactic effect. Although this simple intervention offers one of the few available malaria-preventive measures for regions where malaria is endemic, the observed rebound of severe malaria advises caution and requires further investigation.Keywords
This publication has 35 references indexed in Scilit:
- Intermittent Preventive Antimalarial Treatment in InfantsClinical Infectious Diseases, 2007
- The IPTi Consortium: research for policy and actionTrends in Parasitology, 2006
- Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant MalariaPLoS Medicine, 2006
- A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malariaTropical Medicine & International Health, 2005
- Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and UnderdosingAntimicrobial Agents and Chemotherapy, 2003
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Mortality and morbidity from malaria after stopping malaria chemoprophylaxisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Why do some African children develop severe malaria?Parasitology Today, 1991
- A trial of cotrimoxazole in scabiesBritish Journal of Dermatology, 1979
- WHO Expert Committee on Malaria: Tenth ReportJournal of Parasitology, 1965